NEO PEER ANALYSIS

NeoGenomics Inc — metric-by-metric comparison with peers and the industry median

NEONeoGenomics Inc

🇺🇸 USA · NASDAQ · Healthcare · Diagnostics & Research

Value it Duel

Overall Profile & Returns

· Diagnostics & Research

Position Within Industry

0 = weak quartile, 100 = strong quartile

NEOIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	NEO	TLRY	HLN	DEVA	TNZTP	EGEPO	Ind. Median
P/E	—	—	31.28	—	13.87●	230.70	30.33
P/B	0.47	0.33●	1.98	0.51	1.09	4.31	3.45
EV/EBITDA	—	—	19.15	6.74●	6.80	39.22	20.99
P/S	0.52●	0.60	3.94	0.70	2.64	6.06	4.32

Financial Health
Metric	NEO	TLRY	HLN	DEVA	TNZTP	EGEPO	Ind. Median
Current Ratio	4.42●	2.79	0.92	2.00	2.37	1.76	1.87
Debt/Equity	49.3%	20.4%	52.3%	23.1%	9.2%	2.0%●	49.3%
NetDebt/EBITDA	-7.82●	-0.07	3.50	0.89	-0.40	-0.67	1.92

Profitability
Metric	NEO	TLRY	HLN	DEVA	TNZTP	EGEPO	Ind. Median
Net Margin	-13.3%	-158.8%	12.6%	-4.4%	19.0%●	2.6%	6.7%
ROE	-11.6%	-63.6%	6.3%	-3.6%	9.3%●	2.2%	6.4%
ROA	-6.7%	-49.7%	3.2%	-2.5%	7.5%●	1.8%	3.3%
EBITDA Margin	-4.5%	-156.2%	25.2%	12.0%	36.7%●	15.2%	18.8%

Growth + Dividend
Metric	NEO	TLRY	HLN	DEVA	TNZTP	EGEPO	Ind. Median
Rev. Growth	10.9%	3.8%	-26.7%	7.7%	23.8%●	13.4%	9.1%
NI Growth	—	—	-14.2%●	—	-57.4%	—	12.4%
Div. Yield	—	—	2.0%●	0.0%	0.9%	0.0%	0.8%
Payout	—	—	40.0%	0.0%	12.9%	0.0%	23.2%

Valuation
Metric	NEO	MYGN	FLGT	CSTL	OPK	CDNA	Ind. Median
P/E	—	—	—	—	—	—	30.33
P/B	0.47●	1.66	0.61	1.56	0.96	4.95	3.45
EV/EBITDA	—	—	—	—	—	129.77	20.99
P/S	0.52●	0.68	2.01	2.12	1.98	3.76	4.32

Financial Health
Metric	NEO	MYGN	FLGT	CSTL	OPK	CDNA	Ind. Median
Current Ratio	4.42	2.40	5.31	6.75●	3.61	3.40	1.87
Debt/Equity	49.3%	62.7%	1.0%●	8.0%	33.0%	7.8%	49.3%
NetDebt/EBITDA	-7.82	-0.26	4.55	310.00	-1.59	-15.21●	1.92

Profitability
Metric	NEO	MYGN	FLGT	CSTL	OPK	CDNA	Ind. Median
Net Margin	-13.3%	-48.2%	-23.0%	-3.8%	-36.6%	-2.0%●	6.7%
ROE	-11.6%	-76.7%	-6.8%	-2.8%	-16.9%	-2.4%●	6.4%
ROA	-6.7%	-47.6%	-6.2%	-2.4%	-10.7%	-1.8%●	3.3%
EBITDA Margin	-4.5%	-40.3%	-18.3%	-0.2%	-6.0%	2.6%●	18.8%

Growth + Dividend
Metric	NEO	MYGN	FLGT	CSTL	OPK	CDNA	Ind. Median
Rev. Growth	10.9%	-0.3%	9.5%	-2.1%	-15.7%	19.2%●	9.1%
NI Growth	—	—	—	—	—	—	12.4%
Div. Yield	—	—	—	—	—	—	0.8%
Payout	—	—	—	—	—	—	23.2%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on NEO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.